Join the Pain group to help and get support from people like you.
Pain News (Page 2)
Vertex Advances VX-548 in Acute and Neuropathic Pain
VX-548 advances into pivotal development for people with acute pain; Phase 3 program to initiate in Q4 2022 Phase 2 dose-ranging trial in neuropathic pain expected to initiate by year end...
Vertex Announces Publication of VX-548 Positive Phase 2, Proof-of-Concept Results in New England Journal of Medicine
First published manuscript of VX-548 preclinical and clinical trial results in a peer-reviewed journal BOSTON--(BUSINESS WIRE)--Aug. 3, 2023-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX)...
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain
BOSTON--Jan. 30, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of...
New Insights Into the Persistent Pain of UTIs
MONDAY, March 4, 2024 – People with recurring urinary tract infections frequently have persistent pain, even after antibiotics have cleared the harmful bacteria from their system. Now, researchers...
Factors Identified for Integrative Health and Medicine Use in Chronic Pain
MONDAY, Feb. 12, 2024 – Factors associated with engagement in integrative health and medicine (IHM) and nonpharmacologic modalities versus opioids have been identified for adults with chronic pain,...
Relationship Between Exercise, Pain Not Modified by Cancer History
MONDAY, Feb. 12, 2024 – The relationship between physical activity and pain outcomes does not differ for those with or without a history of cancer, and cancer survivors who engage in more physical...
2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults
WEDNESDAY, Feb. 7, 2024 – Between 2002 and 2022, U.S. adults significantly increased use of complementary health approaches (CHAs), including for pain management, according to a research letter...
Experimental Pain Med Could Give Patients New Option to Opioids
TUESDAY, Jan. 30, 2024 – The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial. For now, the...
'Default' Orders for Palliative Care Speed Relief for Hospital Patients in Pain
WEDNESDAY, Jan 17, 2024 – Palliative care is meant to ease suffering at any stage of disease, but too often many patients wait too long for this type of care to be ordered. Now, researchers at the...
Spinal Cord Stimulation Eases Pain, Boosts Function for People With Prosthetic Legs
FRIDAY, Dec. 15, 2023 – People who've lost a leg due to injury or disease are often plagued by what's known as phantom limb pain – discomfort arising in the area, despite the absence of the limb....
New Syndrome May Be Affecting Babies Exposed to Fentanyl
TUESDAY, Dec. 5, 2023 – Doctors report they are seeing what they think is a new syndrome in babies who are exposed to fentanyl while in the womb. All of the infants have cleft palates and unusually...
Pacira Announces FDA Approval of Expanded Exparel Label to Include Two Additional Nerve Block Indications
Exparel is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — New indications for use as an adductor c...
Few Adults Talk to Providers About BP Risks of OTC Pain Relievers
TUESDAY, Nov. 7, 2023 – Only about 30 percent of U.S. adults have spoken with their health care professional about the adverse effects some over-the-counter pain relievers can have on blood...
Nonsurgical Treatment Works Well for Arthritic Thumbs
TUESDAY, Nov. 7, 2023 – Patients with osteoarthritis in their thumbs can get good long-term outcomes with orthotics and exercise therapy, and avoid surgery at the same time, new research shows. "Our...
ASA: Deep Learning Model Can Improve Pain Assessment
FRIDAY, Oct. 27, 2023 – An automated pain recognition system is promising for detecting pain before, during, and after surgery, according to a study presented at ANESTHESIOLOGY 2023, the annual...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Nocturnal Leg Cramps, Reflex Sympathetic Dystrophy Syndrome, Breakthrough Pain
Related drug support groups
tramadol, gabapentin, ibuprofen, oxycodone, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, pregabalin, duloxetine, diclofenac, methadone, OxyContin, Vicodin, codeine, cyclobenzaprine, Celebrex, Aleve, fentanyl, Advil, Voltaren, morphine, clonidine, Paracetamol Teva, nortriptyline, buprenorphine, Butrans, Paracetamol, Dilaudid, Motrin, cannabis, Tylenol PM, indomethacin, Toradol, Lortab, Ultram, Vistaril, acetaminophen / hydrocodone, Roxicodone, ketamine, Arthritis Pain, Atarax, ketorolac, Percocet 10/325, Nucynta, hydromorphone